Evidence map›Paper›PMID 25891251›Full record

ArticleEpigenetics2015

Prenatal antidepressant exposure associated with CYP2E1 DNA methylation change in neonates.

Cécile Gurnot, Ignacio Martin-Subero, Sarah M Mah, Whitney Weikum, Sarah J Goodman, Ursula Brain, Janet F Werker, Michael S Kobor, Manel Esteller, Tim F Oberlander and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Epigenetics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 4 pooled it
6.0field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 4 syntheses or guidelines pooled it, 76 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 8 institutions in 7 countries.

Cécile Gurnota Center for Brain Science; Department of Molecular Cellular Biology; Harvard University ; Cambridge , MA , USA.
Ignacio Martin-Subero
Sarah M Mah
Whitney Weikum
Sarah J Goodman
Ursula Brain
Janet F Werker
Michael S Kobor
Manel Esteller
Tim F Oberlander
Takao K Hensch
University of British Columbia · CAChild and Family Research Institute · CACanadian Institute for Advanced Research · CAChild Development Center · QAChildren's Hospital · TNInstitució Catalana de Recerca i Estudis Avançats · ESLearning Partnership · CAUniversitat de Barcelona · ES

Funding

Canadian Institutes of Health Research MOP-57837
6 · The paper itself

Abstract

Some but not all neonates are affected by prenatal exposure to serotonin reuptake inhibitor antidepressants (SRI) and maternal mood disturbances. Distinguishing the impact of these 2 exposures is challenging and raises critical questions about whether pharmacological, genetic, or epigenetic factors can explain the spectrum of reported outcomes. Using unbiased DNA methylation array measurements followed by a detailed candidate gene approach, we examined whether prenatal SRI exposure was associated with neonatal DNA methylation changes and whether such changes were associated with differences in birth outcomes. Prenatal SRI exposure was first associated with increased DNA methylation status primarily at CYP2E1(β(Non-exposed) = 0.06, β(SRI-exposed) = 0.30, FDR = 0); however, this finding could not be distinguished from the potential impact of prenatal maternal depressed mood. Then, using pyrosequencing of CYP2E1 regulatory regions in an expanded cohort, higher DNA methylation status--both the mean across 16 CpG sites (P < 0.01) and at each specific CpG site (P < 0.05)--was associated with exposure to lower 3rd trimester maternal depressed mood symptoms only in the SRI-exposed neonates, indicating a maternal mood x SRI exposure interaction. In addition, higher DNA methylation levels at CpG2 (P = 0.04), CpG9 (P = 0.04) and CpG10 (P = 0.02), in the interrogated CYP2E1 region, were associated with increased birth weight independently of prenatal maternal mood, SRI drug exposure, or gestational age at birth. Prenatal SRI antidepressant exposure and maternal depressed mood were associated with altered neonatal CYP2E1 DNA methylation status, which, in turn, appeared to be associated with birth weight.

Indexed as

AdultAntidepressive AgentsCohort StudiesCpG IslandsCytochrome P-450 CYP2E1DNA MethylationFemaleHumansInfant, NewbornLeukocytesMaleMood DisordersParturitionPregnancyPrenatal Exposure Delayed EffectsSelective Serotonin Reuptake InhibitorsAntidepressive AgentsCytochrome P-450 CYP2E1Selective Serotonin Reuptake InhibitorsCNV, copy number variationCYP2E1depressionHAMD, Hamilton Rating Scale for DepressionHR, heart rateneonatal healthpregnancyserotonin reuptake inhibitor (SRI) antidepressantsSRI, serotonin reuptake inhibitor

Identifiers

PMID25891251
PMCPMC4622680
OpenAlexW1871144505

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.